EQUITY ALERT: Rosen Law Firm Continues Investigation of Securities Claims Against Psychemedics Corporation - PMD

NEW YORK, Feb. 3, 2017

On January 31, 2017, it was announced that Psychemedics Corporation's local representative in Brazil, Psychemedics Brasil Exames Toxicologicos Ltda., was ordered on January 20, 2017 to compensate Omega Laboratories, Inc. USA for losses caused by anticompetitive practices used for the purpose of "preventing other companies from accessing (the) market." On this news, shares of Psychemedics fell $6.75 per share or over 26% to close at $18.87 per share on January 31, 2017.

Rosen Law Firm is preparing a class action lawsuit to recover losses suffered by Psychemedics investors. If you purchased shares of Psychemedics on or before January 30, 2017, please visit the firm's website at http://www.rosenlegal.com/cases-1047.html for more information. You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising.  Prior results do not guarantee a similar outcome.